Published in J Infect Dis on February 01, 1999
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
Ebola virus disease. BMJ (2014) 2.63
Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One (2012) 2.33
The emergence of ebola as a global health security threat: from 'lessons learned' to coordinated multilateral containment efforts. J Glob Infect Dis (2014) 1.41
Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic. BMC Med Ethics (2017) 1.39
Viral infections during pregnancy. Am J Reprod Immunol (2015) 1.17
Ebola viral disease and pregnancy. Obstet Med (2015) 1.02
Ebola Virus Disease: Focus on Children. Pediatr Infect Dis J (2015) 0.97
Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection. Obstet Gynecol (2015) 0.89
Emerging and zoonotic infections in women. Infect Dis Clin North Am (2008) 0.89
Delivery of an Ebola Virus-Positive Stillborn Infant in a Rural Community Health Center, Sierra Leone, 2015. Am J Trop Med Hyg (2015) 0.88
Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports. Clin Infect Dis (2015) 0.84
Ebola virus disease and critical illness. Crit Care (2016) 0.82
Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone. J Infect Dis (2016) 0.79
Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks. PLoS Negl Trop Dis (2015) 0.78
Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol (2017) 0.77
Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in Obstetric Services, United States. Emerg Infect Dis (2016) 0.75
A Possible Mechanism of Zika Virus Associated Microcephaly: Imperative Role of Retinoic Acid Response Element (RARE) Consensus Sequence Repeats in the Viral Genome. Front Hum Neurosci (2016) 0.75
Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res (2017) 0.75
Live neonates born to mothers with Ebola virus disease: a review of the literature. J Perinatol (2015) 0.75
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis (1999) 4.18
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (1999) 3.67
Ebola haemorrhagic fever in Kikwit, Zaire. International Scientific and Technical Committee and WHO Collaborating Centre for Haemorrhagic Fevers. Lancet (1995) 3.47
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain. J Med Virol (2004) 2.94
Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 2.70
Rolling out antiretrovirals in Africa: there are still challenges ahead. Clin Infect Dis (2005) 2.43
HIV testing in developing countries. Lancet (1997) 2.19
Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis (1999) 2.06
A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 1.96
Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.86
Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health (1998) 1.75
Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis (1999) 1.73
Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda. Int J STD AIDS (2009) 1.59
Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health (1998) 1.44
Ebola hemorrhagic fever: lessons from Kikwit, Democratic Republic of the Congo. J Infect Dis (1999) 1.41
Euthanasia: from the perspective of HIV infected persons in Europe. HIV Med (2001) 1.40
Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 1.39
Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS (1992) 1.39
Rhodococcus equi infection in 3 AIDS patients. Acta Clin Belg (1996) 1.38
Primary care involvement in human immune deficiency virus infection-a pan-European view. The Eurosupport Study Group. Fam Pract (2000) 1.37
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS (2001) 1.35
Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda. Int J Tuberc Lung Dis (2011) 1.35
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31
[Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo]. Med Trop (Mars) (2003) 1.28
Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Euro Surveill (2015) 1.28
Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in Africa. Lancet (1987) 1.27
Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care (2007) 1.25
Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe. AIDS Care (2004) 1.19
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study. Antivir Ther (2002) 1.19
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS (2000) 1.18
Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need? Int J STD AIDS (2009) 1.18
Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol (1987) 1.17
T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol (2000) 1.17
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol (1991) 1.15
Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981-1985. J Infect Dis (1999) 1.14
Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial. Int J STD AIDS (2011) 1.10
Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. AIDS (1999) 1.08
Sexual dysfunction with protease inhibitors. Lancet (1999) 1.07
Families affected by HIV: parents' and children's characteristics and disclosure to the children. AIDS Care (2004) 1.06
Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes. Antimicrob Agents Chemother (1997) 1.06
Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol (1999) 1.05
Treatment and prevention of multidrug-resistant tuberculosis. Drugs (1999) 1.05
Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett (1998) 1.04
Hospital based clinical surveillance for dengue haemorrhagic fever in Bandung, Indonesia 1994-1995. Acta Trop (2001) 1.04
Evaluation of the WHO clinical case definition for AIDS in rural Zaire. AIDS (1988) 1.04
Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis (2011) 1.01
Uptake of provider-initiated counselling and testing among tuberculosis suspects, Ethiopia. Int J Tuberc Lung Dis (2010) 1.01
Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. Int J Tuberc Lung Dis (2010) 1.00
Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda. Int J STD AIDS (2010) 1.00
Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia. Ann Soc Belg Med Trop (1995) 1.00
Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen. Acta Clin Belg (2006) 0.99
The immune reconstitution inflammatory syndrome related to HIV co-infections: a review. Eur J Clin Microbiol Infect Dis (2011) 0.99
Breastfeeding and transmission of HIV. Lancet (1989) 0.95
Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC) Clin Exp Immunol (1998) 0.95
Cassava food toxins, konzo disease, and neurodegeneration in sub-Sahara Africans. Neurology (2013) 0.94
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol (1997) 0.94
Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 0.93
Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency. Int J STD AIDS (2013) 0.93
Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. Int J Tuberc Lung Dis (2012) 0.92
Comparison of sensitivities and specificities of latex agglutination and an enzyme-linked immunosorbent assay for detection of antibodies to the human immunodeficiency virus in African sera. J Clin Microbiol (1988) 0.92
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. AIDS Res Hum Retroviruses (2000) 0.92
Adult Still's disease caused by Yersinia enterocolitica infection. Arch Intern Med (1984) 0.92
Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda. Int J Tuberc Lung Dis (2013) 0.92
A frontal mucocele caused by an immune reconstitution inflammatory syndrome in a patient with HIV infection. Rhinology (2008) 0.91
Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections. Clin Exp Immunol (1990) 0.90
Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy. Acta Clin Belg (2007) 0.89
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89
Surveillance case definition for AIDS in resource-poor countries. Lancet (1993) 0.89
Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever. J Infect Dis (1999) 0.89
Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment. Infection (2003) 0.89
Birds of a feather: homophily and sexual network structure in sub-Saharan Africa. Int J STD AIDS (2013) 0.88
[Validity of an ELISA test for CD4+ T lymphocyte count and validity of total lymphocyte count in the assessment of immunodeficiency status in HIV infection]. Ann Soc Belg Med Trop (1994) 0.88
Diagnosis of amoebic infection of the liver: report of 36 cases. Ann Soc Belg Med Trop (1995) 0.88
AIDS: an old disease from Africa? Br Med J (Clin Res Ed) (1984) 0.88